We’re getting ahead of HIV.

Ending the HIV epidemic in the U.S. by 2030 is possible by scaling testing, prevention, treatment, and response activities to areas with high rates of HIV. America’s HIV Epidemic Analysis Dashboard (AHEAD) supports this effort by tracking data on 6 HIV indicators that will have the greatest impact on ending the epidemic in local communities and across the U.S.
Knowledge of Status
Linkage to HIV Medical Care
Viral Suppression
PrEP Coverage
Check Icon
National Goals
Reduce number of new HIV infections by 75% by 2025 and 90% by 2030.
In 2019, there were an estimated 34,800
new HIV infections.
Check Icon
National Goals
Increase knowledge of status
to 95% by 2025.
In 2019, 86.7% of people estimated to be
living with HIV have recieved a diagnosis.
Check Icon
National Goals
Decrease confirmed HIV diagnoses
to 25% by 2025 and 10% by 2030.
In 2019, 36,337 people were diagnosed with HIV
Check Icon
National Goals
Increase linkage to care to 95% by 2025.
In 2019, 81.3% of people diagnosed with HIV were linked to care within one month.
Check Icon
National Goals
Increase virally supressed people
to 95% by 2025.
In 2019, 65.5% of people living with diagnosed HIV have low viral load (<200 copies/mL).
Check Icon
National Goals
Increase PrEP coverage to 50% by 2025.
In 2020, 23.0% of people estimated to have PrEP indications are prescribed PrEP.

Ending the HIV epidemic starts at the community level. AHEAD facilitates easy, seamless access to data for EHE priority areas and the American public, focusing on 48 counties, Washington, DC and San Juan, Puerto Rico along with 7 priority states, mostly Southern and rural, with high rates of HIV. AHEAD also shows data for the 43 remaining states for which data are available.

Explore AHEAD

circle with envelope inside

Stay Updated

Stay informed about AHEAD by signing up for periodic email updates from HIV.gov.

Sign Up Now >
person in white sweater


circle with question mark inside


Have questions about the data or suggestions for improvement of the Dashboard? We'd love to hear from you!